Chiara Arienti

2.7k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

Chiara Arienti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chiara Arienti has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Chiara Arienti's work include Cancer Cells and Metastasis (7 papers), 3D Printing in Biomedical Research (5 papers) and DNA Repair Mechanisms (4 papers). Chiara Arienti is often cited by papers focused on Cancer Cells and Metastasis (7 papers), 3D Printing in Biomedical Research (5 papers) and DNA Repair Mechanisms (4 papers). Chiara Arienti collaborates with scholars based in Italy, United States and Germany. Chiara Arienti's co-authors include Anna Tesei, Michele Zanoni, Alessandro Bevilacqua, Alice Zamagni, Filippo Piccinini, Spartaco Santi, R. Polico, Sara Pignatta, Michela Cortesi and Wainer Zoli and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Chiara Arienti

39 papers receiving 2.0k citations

Hit Papers

3D tumor spheroid models for in vitro therapeutic screeni... 2016 2026 2019 2022 2016 250 500 750

Peers

Chiara Arienti
Nina Kramer Austria
Genee Y. Lee United States
Zhuo G. Chen United States
Sritama Nath United States
Miriam Zimmermann United Kingdom
Chiara Arienti
Citations per year, relative to Chiara Arienti Chiara Arienti (= 1×) peers Michele Zanoni

Countries citing papers authored by Chiara Arienti

Since Specialization
Citations

This map shows the geographic impact of Chiara Arienti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Arienti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Arienti more than expected).

Fields of papers citing papers by Chiara Arienti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Arienti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Arienti. The network helps show where Chiara Arienti may publish in the future.

Co-authorship network of co-authors of Chiara Arienti

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Arienti. A scholar is included among the top collaborators of Chiara Arienti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Arienti. Chiara Arienti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arienti, Chiara, Francesca Fanini, Sara Pignatta, et al.. (2024). In vitro CAR-T cell killing: validation of the potency assay. Cancer Immunology Immunotherapy. 73(9). 168–168.
2.
Aramini, Beatrice, Valentina Masciale, Chiara Arienti, et al.. (2022). Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers. 14(10). 2408–2408. 21 indexed citations
3.
Cenni, P., Elisa Neri, Manuela Monti, et al.. (2021). Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma. Frontiers in Oncology. 11. 643469–643469. 6 indexed citations
4.
Zanoni, Michele, Michela Cortesi, Alice Zamagni, et al.. (2020). Modeling neoplastic disease with spheroids and organoids. Journal of Hematology & Oncology. 13(1). 97–97. 166 indexed citations
5.
Pignatta, Sara, Michela Cortesi, Chiara Arienti, et al.. (2020). Effects of radiotherapy and short-term starvation combination on metastatic and non-tumor cell lines. DNA repair. 95. 102949–102949. 10 indexed citations
6.
Storci, Gianluca, Sabrina De Carolis, Alessio Papi, et al.. (2019). Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell Death and Differentiation. 26(9). 1845–1858. 45 indexed citations
7.
Tesei, Anna, Michela Cortesi, Alice Zamagni, et al.. (2018). Sigma Receptors as Endoplasmic Reticulum Stress “Gatekeepers” and their Modulators as Emerging New Weapons in the Fight Against Cancer. Frontiers in Pharmacology. 9. 711–711. 51 indexed citations
8.
Carloni, Silvia, Giulia Gallerani, Anna Tesei, et al.. (2017). DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy. OncoTargets and Therapy. Volume 10. 4657–4664. 3 indexed citations
9.
Piccinini, Filippo, Anna Tesei, Chiara Arienti, & Alessandro Bevilacqua. (2017). Cell Counting and Viability Assessment of 2D and 3D Cell Cultures: Expected Reliability of the Trypan Blue Assay. Biological Procedures Online. 19(1). 8–8. 93 indexed citations
10.
Zanoni, Michele, Filippo Piccinini, Chiara Arienti, et al.. (2016). 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Scientific Reports. 6(1). 19103–19103. 838 indexed citations breakdown →
11.
Piccinini, Filippo, Anna Tesei, Chiara Arienti, & Alessandro Bevilacqua. (2014). Cancer multicellular spheroids: Volume assessment from a single 2D projection. Computer Methods and Programs in Biomedicine. 118(2). 95–106. 57 indexed citations
12.
Pignatta, Sara, Chiara Arienti, Wainer Zoli, et al.. (2013). Prolonged exposure to ( R )-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome. Molecular and Cellular Endocrinology. 382(1). 314–324. 12 indexed citations
13.
Tesei, Anna, Carlo Leonetti, Marzia Di Donato, et al.. (2013). Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models. PLoS ONE. 8(5). e62657–e62657. 15 indexed citations
14.
Tesei, Anna, Anna Sarnelli, Chiara Arienti, et al.. (2013). In vitro irradiation system for radiobiological experiments. Radiation Oncology. 8(1). 257–257. 30 indexed citations
15.
Arienti, Chiara, Anna Tesei, Giorgio Maria Verdecchia, et al.. (2013). Role of Conventional Chemosensitivity Test and Tissue Biomarker Expression in Predicting Response to Treatment of Peritoneal Carcinomatosis From Colon Cancer. Clinical Colorectal Cancer. 12(2). 122–127. 17 indexed citations
16.
Fabbri, Francesco�, Wainer Zoli, Silvia Carloni, et al.. (2011). Activity of different anthracycline formulations in hormone‐refractory prostate cancer cell lines: Role of golgi apparatus. Journal of Cellular Physiology. 226(11). 3035–3042. 6 indexed citations
17.
Ulivi, Paola, Chiara Arienti, Dino Amadori, et al.. (2009). Role of RAF/MEK/ERK pathway, p‐STAT‐3 and Mcl‐1 in sorafenib activity in human pancreatic cancer cell lines. Journal of Cellular Physiology. 220(1). 214–221. 68 indexed citations
18.
Tesei, Anna, Wainer Zoli, Chiara Arienti, et al.. (2009). Isolation of stem/progenitor cells from normal lung tissue of adult humans. Cell Proliferation. 42(3). 298–308. 29 indexed citations
19.
Ulivi, Paola, Chiara Arienti, Anna Tesei, et al.. (2008). Different mechanisms involved in the activity of BAY 43-9006 (Sorafenib) in human pancreatic cancer cell lines. Cancer Research. 68. 2809–2809. 1 indexed citations
20.
Arienti, Chiara, Anna Tesei, Alberto Ravaioli, et al.. (2008). Activity of lipoplatin in tumor and in normal cells in vitro. Anti-Cancer Drugs. 19(10). 983–990. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026